View Clinical Trial (Medical Research Study)

Buprenorphine and Integrated HIV Care Evaluation - NCT00124358-85745(Clinical Trial 126264)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Tucson
State:  
AZ
Zip Code: 85745
Conditions: Opioid-Related Disorders - HIV Infections - AIDS
Purpose: The purpose of this study is to assess the feasibility, cost and effectiveness of interventions designed to integrate buprenorphine treatment for opioid dependence into HIV primary care in ten HIV care centers in the U.S.
Study summary: Programs that integrate medical care and drug treatment have shown great promise in improving health and substance use related outcomes. The overlap in the epidemics of HIV (with its complex medical needs) and drug abuse makes HIV-infected drug users a population likely to benefit from the integration of primary care and drug treatment. The Drug Addiction Treatment Act of 2000 and the approval of buprenorphine for the office-based treatment of opioid addiction provide a new opportunity to integrate addiction treatment and medical care for people with HIV. Research has demonstrated the effectiveness of buprenorphine in reducing illicit drug use among opioid dependent people. However, little is known about implementing such programs in HIV care settings, their cost, what effect they have on the health outcomes and substance use behavior of PLWH/A, or their broader impact on providers, institutions, and local systems. Through this study, approximately 1,350 HIV-infected individuals who meet criteria for opioid dependence will be selected by eleven model demonstration projects located in ten HIV care centers across the U.S. Information on patients’ drug use, HIV health status, service utilization, quality of life, and satisfaction with services as well as information about providers’ practices and attitudes towards treating drug dependent patients will be collected through face-to-face interviews, audio computer-assisted self-interviewing, written surveys, and chart abstractions. These data will be used to help replicate effective programs that integrated HIV care and drug treatment and to improve the care of HIV-infected opioid dependent individuals. Comparisons: All eleven programs will compare a group of patients who receive integrated buprenorphine treatment and HIV care to a group of patients who receive an alternate intervention. However, the program designs and comparison group interventions vary across the sites and are locally determined. Some sites will implement randomized control designs, while others will use observational methods.
Criteria: Inclusion Criteria: - HIV-infected - Clinical diagnosis of opioid dependence - Fluent in English or Spanish - 18 years or older Exclusion Criteria: - Liver function tests (transaminase only) at five times or higher than normal level; - Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV) criteria for benzodiazepine abuse or dependence within the past 6 months; - DSM-IV criteria for alcohol dependence within the past 6 months; - Actively suicidal; - Psychiatric impairment that impedes ability to consent (dementia, delusional, actively psychotic); - Methadone dose exceeding levels allowing for safe transition to buprenorphine; - Pregnant women and women actively trying to become pregnant; - Clinical judgment of local site principal investigator that patient is inappropriate
Study is available at: El Rio Santa Cruz Neighborhood Health Center
Tucson, AZ 85745
United States

Primary Contact:
Jeff Thomas, ACSW
Email: jefft@elrio.org
Phone: 520-629-2888

Secondary Contact:
Ruth Finkelstein, ScD
Email: rfinkelstein@nyam.org
Phone: 212.822.7266
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 21, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.